ArticleCureus2024
Factors Affecting Non-sentinel Lymph Node Metastasis in Early-Stage Breast Cancer.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Breast cancer most commonly metastasizes to axillary lymph nodes via lymphatic drainage. Today, axillary lymph node surgery is at least as important as primary breast surgery. In today's breast surgery, supported by chemotherapy and radiotherapy, current approaches are taken to avoid axillary dissection in appropriate patient groups. In our study, we aimed to evaluate and predict the factors affecting non-sentinel lymph node metastasis in patients with early-stage clinically node-negative breast cancer. Materials and methods Data of 65 female patients were analysed retrospectively. Patient's age, preoperative haemoglobin values, tumour localisation, tumour diameter, number of sentinel lymph nodes sent for frozen examination, and tumour pathological features were investigated in terms of the number of non-sentinel lymph nodes and metastatic lymph nodes removed by axillary dissection, and whether it affects non-sentinel lymph node metastasis was investigated by statistical analysis. Results In the axillary dissection of patients with positive sentinel lymph node metastasis, the number of metastatic non-sentinel lymph nodes was statistically significantly higher in Cerb-B2-positive patients than in Cerb-B2-negative patients (p=0.046). As the stage progressed, the number of metastatic non-sentinel lymph nodes increased as expected (p<0.001). Conclusion In the current axillary surgery, it is a new approach to avoid axillary dissection in appropriate patient groups even if the sentinel lymph node is positive. When planning the surgical treatment of these patients, it should be considered preoperatively that Cerb-B2-positive patients are more prone to axillary non-sentinel lymph node metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.